Is history of squamous-cell skin cancer a marker of poor prognosis in patients with cancer?

Ann Intern Med. 1999 Nov 2;131(9):655-9. doi: 10.7326/0003-4819-131-9-199911020-00004.

Abstract

Background: Nonmelanoma skin cancer is associated with increased occurrence of subsequent cancer and death from cancer, but it is not known whether a history of skin cancer is associated with poor prognosis after a second diagnosis of cancer.

Objective: To determine whether history of squamous-cell skin cancer is a marker of poor prognosis in patients with cancer.

Design: Population-based cohort study.

Setting: Sweden, 1958 to 1996.

Patients: All patients in the Swedish Cancer Registry with or without a first diagnosis of squamous-cell skin cancer and a subsequent or first diagnosis of non-Hodgkin lymphoma (including chronic lymphocytic leukemia) or cancer of the colon, breast, prostate, or lung.

Measurements: Relative risk (RR) for death determined by using Cox proportional hazards regression analysis.

Results: Patients with a history of squamous-cell skin cancer had a significantly greater risk for death than those with no such history after receiving a diagnosis of non-Hodgkin lymphoma (RR, 1.33), colon cancer (RR, 1.24), breast cancer (RR, 1.19), or prostate cancer (RR, 1.17). Patients with lung cancer and a history of squamous-cell skin cancer who survived for 1 year after diagnosis of lung cancer also had an increased risk for death (RR, 1.29).

Conclusion: Patients with a registered history of squamous-cell skin cancer have a poor prognosis after diagnosis of subsequent cancer and warrant careful medical attention.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Breast Neoplasms / mortality
  • Carcinoma, Squamous Cell*
  • Colonic Neoplasms / mortality
  • Female
  • Humans
  • Lung Neoplasms / mortality
  • Lymphoma, Non-Hodgkin / mortality
  • Male
  • Middle Aged
  • Mortality
  • Neoplasms, Second Primary* / mortality
  • Prognosis
  • Proportional Hazards Models
  • Prostatic Neoplasms / mortality
  • Regression Analysis
  • Risk Factors
  • Skin Neoplasms*